Cholecystokinin (CCK) is a gut peptide hormone known to stimulate postprand
ial gallbladder contraction and pancreatic enzyme secretion. It has also be
en shown to induce the growth of normal pancreas and of malignant and prema
lignant lesions in rodents. Although CCK has been shown to promote the grow
th of human adenocarcinoma cell lines, its rule in the growth of human panc
reatic adenocarcinomas in vivo is less clear. Localization of CCK receptors
to neoplastic cells within resected human tissue specimens would be sugges
tive of its potential action as an in vivo promoter of human pancreatic can
cer. Resected tissue specimens of pancreatic adenocarcinomas were therefore
studied by both reverse transcriptase-polymerase chain reaction (RT-PCR) a
nd in situ hybridization for the presence of CCK-A receptors. Ninety percen
t of studied tumors demonstrated CCK-A expression by RT-PCR, and this expre
ssion was localized to neoplastic cells by in situ hybridization. An increa
se in the expression of CCK receptors is a mechanism by which pancreatic ma
lignancies may gain a significant growth stimulus.